Skip to main content
NVDA+2.56%AAPL+0.78%GOOGL+1.59%MSFT+1.03%AMZN+1.90%TSM+1.99%SPCX-0.09%META+12.05%AVGO+1.34%TSLA+3.11%SKHY+0.34%MU+2.84%LLY+1.42%BRK-B-0.91%AMD+8.65%JPM+0.71%WMT+0.72%V+0.16%XOM-2.53%JNJ+0.45%ASMLa+2.45%INTC+11.60%0700.HK+2.63%MA+0.21%ABBV+0.59%1398.HK+1.07%CSCO+1.37%ORCL+0.73%BAC+0.77%CVX-2.00%COST+0.34%DELL+2.21%KO-0.33%CAT+1.23%LRCX+5.03%AMAT+4.64%AP2d+5.60%0005.HK-0.06%HSBA.L+1.40%PG+0.12%UNH+0.19%ARM+16.14%GE+2.11%3988.HK+1.17%MS+1.96%1816.HK-0.24%NFLX+2.39%0939.HK+1.77%0857.HK+0.21%HD-0.27%PLNJPY+0.60%CHFJPY+0.50%CHFNOK+0.47%CADCHF-0.44%GBPTRY+0.41%EURPLN-0.41%USDNOK+0.38%USDJPY+0.38%USDCAD+0.35%AUDJPY+0.33%SGDJPY+0.32%AUDNOK+0.32%GBPHKD+0.32%AUDCAD+0.31%GBPMXN-0.28%GBPCHF-0.28%EURCHF-0.27%NZDJPY+0.26%CHFSEK+0.22%EURCNH-0.22%USDPLN-0.21%NZDCAD+0.21%USDTHB-0.21%NZDCHF-0.20%EURUSD-0.20%GBPZAR-0.20%USDDKK+0.20%GBPUSD-0.20%EURZAR-0.19%EURHKD-0.19%GBPJPY+0.18%EURNOK+0.18%EURJPY+0.17%USDILS+0.16%GBPCAD+0.16%NZDMXN-0.16%GBPSGD-0.15%EURSGD-0.15%GBPAUD-0.15%AUDDKK+0.14%NZDUSD-0.14%EURAUD-0.14%CHFSGD+0.14%USDSEK+0.14%AUDCHF-0.12%EURCZK-0.12%EURCAD+0.12%USDCHF-0.10%NZDSGD-0.10%EURNZD-0.09%AUDNZD+0.09%USDTRY+0.07%EURSEK-0.06%USDCNH-0.06%GBPNZD-0.06%USDSGD+0.05%AUDUSD-0.04%USDCOP-0.04%CADJPY+0.02%USDMXN-0.01%USDZAR+0.01%NOKJPY+0.01%EURGBP+0.01%USDHKD+0.01%AUDSGD-0.01%EURDKK0.00%USOIL-3.17%UKOIL-2.51%XNGUSD-1.47%HG1+0.96%XAUUSD-0.75%GAUUSD-0.75%GAGUSD-0.38%XAGUSD-0.37%XPTUSD+0.28%C10.00%COFFEE0.00%COCOA0.00%BTCUSD+5.96%ETHUSD+4.09%USDTUSD-0.02%XRPUSD+7.01%SOLUSD+5.83%TRXUSDT+0.41%ZECUSDT-1.55%DOGEUSD+13.95%XMRUSDT+1.00%LINKUSD+3.50%XLMUSD+6.08%UNIUSD+0.30%BCHUSDT+4.74%LTCUSD+5.04%HBARUSDT+5.03%SUIUSD+12.59%TONUSD+23.87%TAOUSDT+9.13%AAVEUSD+4.56%DOTUSDT+3.24%ICPUSDT+0.62%ONDOUSDT+1.80%ARBUSDT+3.57%WLDUSDT-1.36%JUPUSDT-1.21%ATOMUSDT+1.75%INJUSDT+0.33%STXUSDT-0.36%FETUSDT+14.04%SEIUSDT+11.46%TIAUSDT+3.37%PYTHUSDT+3.49%IMXUSDT+7.43%GRTUSDT+5.47%OPUSDT-0.46%WIFUSDT+20.37%POLUSDT+2.20%IOTAUSDT-0.40%FARTCOINUSDT+12.18%AXSUSDT+4.75%EOSUSDT+3.92%DYDXUSDT+4.90%ORDIUSDT+5.18%GALAUSDT+8.51%NOTUSDT+2.06%RONINUSDT+7.71%NVDA+2.56%AAPL+0.78%GOOGL+1.59%MSFT+1.03%AMZN+1.90%TSM+1.99%SPCX-0.09%META+12.05%AVGO+1.34%TSLA+3.11%SKHY+0.34%MU+2.84%LLY+1.42%BRK-B-0.91%AMD+8.65%JPM+0.71%WMT+0.72%V+0.16%XOM-2.53%JNJ+0.45%ASMLa+2.45%INTC+11.60%0700.HK+2.63%MA+0.21%ABBV+0.59%1398.HK+1.07%CSCO+1.37%ORCL+0.73%BAC+0.77%CVX-2.00%COST+0.34%DELL+2.21%KO-0.33%CAT+1.23%LRCX+5.03%AMAT+4.64%AP2d+5.60%0005.HK-0.06%HSBA.L+1.40%PG+0.12%UNH+0.19%ARM+16.14%GE+2.11%3988.HK+1.17%MS+1.96%1816.HK-0.24%NFLX+2.39%0939.HK+1.77%0857.HK+0.21%HD-0.27%PLNJPY+0.60%CHFJPY+0.50%CHFNOK+0.47%CADCHF-0.44%GBPTRY+0.41%EURPLN-0.41%USDNOK+0.38%USDJPY+0.38%USDCAD+0.35%AUDJPY+0.33%SGDJPY+0.32%AUDNOK+0.32%GBPHKD+0.32%AUDCAD+0.31%GBPMXN-0.28%GBPCHF-0.28%EURCHF-0.27%NZDJPY+0.26%CHFSEK+0.22%EURCNH-0.22%USDPLN-0.21%NZDCAD+0.21%USDTHB-0.21%NZDCHF-0.20%EURUSD-0.20%GBPZAR-0.20%USDDKK+0.20%GBPUSD-0.20%EURZAR-0.19%EURHKD-0.19%GBPJPY+0.18%EURNOK+0.18%EURJPY+0.17%USDILS+0.16%GBPCAD+0.16%NZDMXN-0.16%GBPSGD-0.15%EURSGD-0.15%GBPAUD-0.15%AUDDKK+0.14%NZDUSD-0.14%EURAUD-0.14%CHFSGD+0.14%USDSEK+0.14%AUDCHF-0.12%EURCZK-0.12%EURCAD+0.12%USDCHF-0.10%NZDSGD-0.10%EURNZD-0.09%AUDNZD+0.09%USDTRY+0.07%EURSEK-0.06%USDCNH-0.06%GBPNZD-0.06%USDSGD+0.05%AUDUSD-0.04%USDCOP-0.04%CADJPY+0.02%USDMXN-0.01%USDZAR+0.01%NOKJPY+0.01%EURGBP+0.01%USDHKD+0.01%AUDSGD-0.01%EURDKK0.00%USOIL-3.17%UKOIL-2.51%XNGUSD-1.47%HG1+0.96%XAUUSD-0.75%GAUUSD-0.75%GAGUSD-0.38%XAGUSD-0.37%XPTUSD+0.28%C10.00%COFFEE0.00%COCOA0.00%BTCUSD+5.96%ETHUSD+4.09%USDTUSD-0.02%XRPUSD+7.01%SOLUSD+5.83%TRXUSDT+0.41%ZECUSDT-1.55%DOGEUSD+13.95%XMRUSDT+1.00%LINKUSD+3.50%XLMUSD+6.08%UNIUSD+0.30%BCHUSDT+4.74%LTCUSD+5.04%HBARUSDT+5.03%SUIUSD+12.59%TONUSD+23.87%TAOUSDT+9.13%AAVEUSD+4.56%DOTUSDT+3.24%ICPUSDT+0.62%ONDOUSDT+1.80%ARBUSDT+3.57%WLDUSDT-1.36%JUPUSDT-1.21%ATOMUSDT+1.75%INJUSDT+0.33%STXUSDT-0.36%FETUSDT+14.04%SEIUSDT+11.46%TIAUSDT+3.37%PYTHUSDT+3.49%IMXUSDT+7.43%GRTUSDT+5.47%OPUSDT-0.46%WIFUSDT+20.37%POLUSDT+2.20%IOTAUSDT-0.40%FARTCOINUSDT+12.18%AXSUSDT+4.75%EOSUSDT+3.92%DYDXUSDT+4.90%ORDIUSDT+5.18%GALAUSDT+8.51%NOTUSDT+2.06%RONINUSDT+7.71%
MT

MapLight Therapeutics, Inc. (MPLT)

NASDAQ • Healthcare

$10.92
-$0.4 (-3.5%)
Market open

Last close at September 18, 2026 at 20:00 UTC

Open$11.21
Previous Close$10.92
Day Range$10.51 - $11.21
Avg. Volume (3M)644.3K
Market Cap$466.3M
52 Week Range
$9.1$40.43
Next EarningsIn 73 daysDec 3, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$229.8M
EPS (TTM)
-$5.18
ROA (TTM)
-62.39%
Current Ratio
16.52

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-27.9%Q2 2026-$1.34
+2.2%Q3 2026-$1.32
+2.2%Q3 2026-$1.32
Next

Dec 3

in 73 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +2.2%

MapLight Therapeutics’ preliminary second fiscal quarter of 2026 results, reported September 18, 2026, featured EPS of -$1.32, which topped the -$1.35 estimate by $0.03, while the company posted a GAAP net loss of about $60.2 million, down from roughly $29.8 million a year ago (net income YoY -101.7%). GAAP operating income was also negative at around $63.5 million, consistent with the company’s clinical-stage profile as it advances central nervous system programs such as ML-007C-MA and ML-004 rather than generating commercial revenue. On the cash side, MapLight recorded negative operating cash flow of roughly $44.9 million. On a year-over-year basis, EPS declined -144.4% from -$0.54 a year ago. Consensus for the next period calls for EPS of -$1.18.

View full earnings history

About MapLight Therapeutics, Inc.

MapLight Therapeutics, Inc. develops clinical-stage biotechnology therapies for severe central nervous system disorders and trades on NASDAQ under the ticker MPLT. The company develops neuropsychiatric drug candidates from a proprietary platform designed to identify and modulate disease-linked neural circuits, and it operates as a subsidiary of Catalyst4, Inc.

Name
MapLight Therapeutics, Inc.
CEO
Christopher A. Kroeger
Website
www.maplightrx.com
Industry
Healthcare
Year Founded
2018
Employees
133

Today's Snapshot

AI-generated

So far today, MPLT is trading slightly higher at 10.96, while its sector was firmer.

Trading Volume

Below 10d avg (579.0K)

216K

vs S&P 500 Today

Underperforming Market

-0.88%

Updated: September 21, 2026 at 17:02 UTC

Technical Indicators

1 Buy2 Neutral5 Sell
MPLT exhibits a pronounced bearish tone with a firm trend reading (ADX roughly 31) accompanied by weak momentum and deep negative CCI, while short and medium moving averages sit well above the current price and 200-day averages remain considerably higher. Volatility is elevated with ATR near 1.12 (about 10%), and on‑balance volume is slumping, reinforcing distribution. Although the price is marginally above VWAP, the weight of momentum, trend and moving‑average signals supports a decisive downside bias. Technical takeaway: Strong Sell.
All signals
  • EMA (5 indicators)$11.99 - $19.99
    Sell
  • RSI (14)32.56
    Neutral
  • Stochastic %K (14, 3, 3)10.41
    Buy
  • MACD Level (12, 26)-1.27
    Neutral

Peers & Related Assets

DWTXDogwood Therapeutics, Inc.
EDSAEdesa Biotech, Inc.
LPCNLipocine Inc.
PMNProMIS Neurosciences, Inc.
IMRNImmuron Limited
TRAWTraws Pharma, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.